FDA ap­proves Ab­b­Vie's 24-hour Parkin­son's in­fu­sion ther­a­py af­ter two CRLs

The FDA has fi­nal­ly ap­proved Ab­b­Vie’s in­fused Parkin­son’s drug for pa­tients who don’t re­spond to wide­ly used oral ther­a­pies.

The drug, for­mer­ly known as AB­BV …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER